Position in TLRY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,604,560
-$930,350 QoQ
Shares Held
248,000
-11.7% QoQ
Ownership
0.213%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 16%
Shared 0%
None 84%
Common Shares in TLRY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $7,513,489,070 across 54 Drug Manufacturers - Specialty & Generic names. TLRY ranks #41 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
19,324,401 | $2,284,337,442 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,843,963 | $1,093,433,179 | |
| 3 | VTRS |
Viatris Inc
|
52,233,699 | $705,677,273 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
4,354,526 | $573,665,255 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
17,790,020 | $535,835,402 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
15,336,479 | $367,001,942 | |
| 7 | ALKS |
Alkermes plc.
|
9,465,286 | $334,692,512 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
2,429,803 | $184,300,557 |
All Filings in TLRY
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,604,560 | 248,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,534,910 | 280,721 | Shares | Defined | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||